Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
biosimulytics logo — AI-powered molecular modelling for accelerated and smarter d...

biosimulytics

AI-powered molecular modelling for accelerated and smarter drug development

Founded 2019 Ireland Ireland 7 employees Grant Total: $595.00K AI, Pharmaceutical +1

General Information

Company Name biosimulytics
Founded Year 2019
Location Ireland Ireland
Employees 7
Industries AI, Pharmaceutical, Machine Learning
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with biosimulytics. To contact biosimulytics, visit biosimulytics.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does biosimulytics compare?

A PDF of biosimulytics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting biosimulytics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About biosimulytics

BioSimulytics is an AI-powered molecular modelling startup focused on revolutionizing the drug development process. Founded in 2019 as a spin-out from the School of Chemical & Bioprocess Engineering of University College Dublin (UCD) in Ireland, the company leverages advanced neural network technology, molecular modelling, quantum physics, and high-performance computing to advance next-generation drug development in the pharma/biotech sector. A key focus is on rapidly predicting polymorphism, a known challenge in the pharmaceutical industry. Additionally, the technology is applied to predicting stable binding poses in protein-ligand complexes for structure-based drug design. The company secured a grant investment from EIC Accelerator on 20 June 2023, demonstrating investor confidence in their innovative approach. BioSimulytics aims to address pressing healthcare needs by unlocking new and improved therapies faster and more cost-efficiently.

Business keywords: AI-powered technology, Molecular modelling, Drug development, Neural network technology, Quantum physics, High performance computing, Pharma/biotech sector, Therapy optimization, Healthcare innovation, Polymorphism prediction, Structure-based drug design, Software development, University spin-out, Research and development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
EIC Accelerator
20 Jun 2023
Seed Round €595.00K 1
Enterprise Ireland
Enterprise Ireland
02 Sep 2021

Latest News

View All
A showcase of Europe's impact-driven innovators – EIT Awards winners announced [Advertorial] — Tech
A showcase of Europe's impact-driven innovators – EIT Awards winners announced [Advertorial]
Tech Feb 22, 2024
Europe's most promising innovations to compete for up to 50,000 EUR at the EIT Awards 2024 [Advertor... — Tech
Europe's most promising innovations to compete for up to 50,000 EUR at the EIT Awards 2024 [Advertorial]
Tech Feb 19, 2024

biosimulytics Alternatives & Competitors

View All Alternatives
biosimulytics vs
PharmCADD
PharmCADD Korea South

PharmCADD is a company designed to accelerate drug discovery using technologies of AI and Molecular...

Series B
16 employees
AI, Biotechnology
biosimulytics vs
Mach42
Mach42 United States

The AI-driven acceleration company.

Seed
20 employees
AI, Machine Learning
biosimulytics vs
Pharmacelera
Pharmacelera Spain

Mine enhanced chemical space. Design superior candidates

Seed
28 employees
Biotechnology, Information Technology
View all alternatives

FAQ About biosimulytics

AI-powered molecular modelling for accelerated and smarter drug development
biosimulytics was founded in 2019.
biosimulytics is headquartered in Ireland.
biosimulytics operates in AI, Pharmaceutical and Machine Learning. Its work centres on AI-powered technology, Molecular modelling, Drug development and Neural network technology.
biosimulytics has approximately 7 employees.
biosimulytics has completed 2 funding rounds, raising a total of $595.00K. The latest funding stage is Grant.
Top alternatives and competitors to biosimulytics include PharmCADD, Mach42, Pharmacelera, Tenstorrent, Deargen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
biosimulytics and PharmCADD are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for biosimulytics, https://bouncewatch.com/company/biosimulytics, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes